White House’s $215M precision medicine initiative ushers in new era in healthcare

Laura Pedulli | | Health Exec | Policy & Regulations

The White House announced that it is pumping $215 million into federal health and science agencies so they can develop infrastructure that allows data to flow between medical clinics to labs that sequence the human genome and gather other data, reports Politico.

The Precision Medicine Initiative, first mentioned in President Obama’s State of the Union Address, ultimately seeks to find more targeted personalized approaches to treatments and cures, according to the story.

Read more below:

Obama’s ‘precision medicine’ initiative could bring insight into disease

Laura Pedulli

Related Content

Report: UnitedHealth under investigation by DOJ for Medicare Advantage upcoding
FDA approves first therapy for very rare lipid storage disorder
FDA announces Class I recall of Boston Scientific pacemakers—replacement may be necessary
FDA ends semaglutide shortage, closing the door on compounded Wegovy, Ozempic
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues
Federal judge sides with FTC; case against PBMs to move forward

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”